Annual Health Expenditures by Body Mass Index Categories and the Economic Impact of Obesity in Türkiye: A Retrospective Modeling Study
Obesity is both an individual and social health problem, which emphasizes the potential role of a range of stakeholders, besides the health sector, in addressing this problem. The indirect costs comprise the key cost driver of the total national cost of obesity, which forms the rationale for population-wide policy interventions toward prevention or reduction of obesity.
Authors
- Lâle Tokgözoğlu (ORCID: https://orcid.org/0000-0001-6441-3339)
- Volkan Yumuk (ORCID: https://orcid.org/0000-0001-6463-4916)
- Di̇lek Gogas Yavuz (ORCID: https://orcid.org/0000-0002-0075-6313)
- E Öksüz (ORCID: https://orcid.org/0000-0002-5723-5965)
- Esra Şafak Yılmaz (ORCID: https://orcid.org/0000-0003-2715-4600)
- Alper Sönmez (ORCID: https://orcid.org/0000-0002-9309-7715)
- S Malhan (ORCID: https://orcid.org/0000-0001-9853-4753)
- Mehmet Sargın (ORCID: https://orcid.org/0000-0003-4793-6941)
- Tarkan Karakan (ORCID: https://orcid.org/0000-0003-1561-8789)
- Batu Gürser
- Halil Alış (ORCID: https://orcid.org/0000-0003-0907-6047)
Institutions
- Ministry of Health (TR)
- University of Health Science (KH)
- Istanbul Aydın University (TR)
- Başkent University (TR)
- Novo Nordisk (Denmark) (DK)
- Novo Nordisk (Switzerland) (CH)
- Istanbul University-Cerrahpaşa (TR)
- Güven Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul Medeniyet University (TR)
- Hacettepe University (TR)
- Marmara University (TR)
- University of Health Sciences Antigua (AG)
- Gazi University (TR)
Publication Details
- Journal
- Obesity Facts
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1159/000542821
- Primary Topic
- Global Health Care Issues
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk